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Abstract: Ganglioside mimicry by C. jejuni lipo-oligosaccharides (LOS) could induce the 
production of autoantibodies against gangliosides and the development of Guillain-Barré 
syndrome (GBS). The LOS biosynthesis region exhibits significant variation with different 
strains. Using PCR amplifications of genes from published LOS loci and sequencing the 
LOS biosynthesis loci,  the eight GBS-associated C.  jejuni strains from HeBei could be 
classified into four classes.  The expression of sialylated LOS structures (class A) or 
non-sialylated LOS structures(class F, H and P) in the C. jejuni LOS is considered to be two 
different factors for the induction of GBS. 
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1. Introduction 
Campylobacter jejuni (C. jejuni) is the leading cause of acute bacterial gastroenteritis worldwide. It 
has been associated with the development of Guillain-Barré syndrome (GBS), a post-infectious 
polyneuropathy [1–4]. The association between C. jejuni and the development of GBS is thought to 
result from the molecular mimicry between outer core structures of bacterial lipo-oligosaccharides 
(LOS) and gangliosides in peripheral nerves [1,2,4–6]. LOS of C. jejuni display considerable variation 
in the outer core structure. Microarray and PCR probing studies have shown that there is extensive 
variation in the gene content of the locus [7]. Based on gene content and organization, the loci are 
divided into eight classes (Class A through H) [8]. Many studies indicate that the Class A locus is 
predominately associated with GBS [8-10]. A recent study identified 11 new classes of LOS loci that 
were distinctly different from the previous eight classes [11]. They demonstrated the insertions and 
deletions of genes were related among different LOS classes. In the present study, the characteristics of 
loci involved in the biosynthesis of the LOS outer core from eight C. jejuni strains isolated from GBS 
patients in Hebei, China were studied.   
2. Results and Discussion 
2.1. Gene Contents and Organizations of the LOS Biosynthesis Loci in 8 C. jejuin Strains 
According to the general organization of the LOS biosynthesis genes, the eight C. jejuni strains in 
this study could be classified into four classes “A,” “F,” “H,” and “P”. Four strains, QYT, LXC, ZHX, 
and ZB, which have 13 ORFs and only one copy of cgtA gene (orf5) in a 12.2-kb locus, belonged to 
class A. The 12.2-kb DNA sequences among the four Class A strains had 98% identity. An alignment 
of the deduced protein sequences of the cstII gene (sialytransferase) from four class A strains gave 
96% identity. Three strains (LXC, ZHX and ZB) had mono-functional CstII (Thr51) and strain QYT 
had bi-functional CstII character with Asn51, Leu-54, and Ile-269. There was also a missing A base at 
position 1,234 of orf3 in these class A strains which were consisted with previous description [9].   
Strain XWM has 9 ORFs in a 8.5-kb locus, and belonged to Class F. It lacks the neuBCA and cst 
genes and likely directs the synthesis of nonsialylated LOS structures. The DNA sequence of the 
8.5-kb LOS of strain XWM showed a 99.7% identity with strain RM1170, and showed 99.3% identity 
with strain GB15, which were both identified as Class F [11]. 
Strain LC has 18 ORFs in a 14.8-kb locus, which showed a 99.0% DNA sequence identity to strain 
RM1047, belonged to Class H. Two strains, LL and ZX, belonged to Class P, which had 19 ORFs in a 
15.8-kb locus with 99.8% DNA sequence identity to strain GB4 [8,11]. 
2.2. Discussion 
So far, 46 ORFs were found in LOS loci and 19 major LOS classes: A-S, were identified based on 
gene content and organization of the LOS biosynthesis loci [1]. Classes A, B, and C were involved in 
sialylated LOS synthesis [9,12–16]. The present study described the LOS characteristics of eight C. 
jejuni strains isolated from GBS patients from north China. Four of them belonged to Class A, which 
was consistent with previous reports [8–10,16]. Classes F, H, and P were found in four strains that Int. J. Mol. Sci. 2010, 11                         
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possessed non-sialylated LOS structure. The presence of these four classes of LOS loci demonstrated 
genetic rearrangements and the complexity of LOS biosynthesis loci in GBS associated  C.  jejuni 
strains. However, no additional experiments have been done on analysing the LOS structure and the 
gangliosides mimics of each strain. With respect to other non-ganglioside-like structures (class F, H 
and P) that may be involved in molecular mimicry in the development of GBS. Godschalk et al. have 
demonstrated that co-infection with multiple  C. jejuni  strains also occurs in GBS patients [10]. 
Co-infections with multiple C. jejuni  strains might be an alternative explanation to these classes. 
Although the presence of certain C. jejuni genes involved in sialylated LOS biosynthesis may be 
crucial for induction of the anti-ganglioside immune response that leads to GBS, the genetic 
susceptibility of host may also contribute to differences in clinical outcomes of the patients [8,14,20].   
Besides the gene content, DNA sequence of this locus from multiple strains indicated that C.jejuni 
used other mechanisms to vary its outer core: phase variation because of homopolymeric tracts, gene 
inactivation by the deletion of a single base (without phase variation) and single or multiple mutations 
leading to allelic  glycosyltransferases  [9].Nam Shin et al. have observed that the absence of a 
β-1,2-glucosyl residue on Hep-II makes possible the sialylation of the inner β-1,3-Gal residue by CstII 
[18].  Gilbert  et al. suggested that the inactivation of the second domain of orf3  by a frameshift 
mutation is the genetic basis for the absence of a β-1,2-glucosyl residue on Hep-II [9]. In this study, we 
also found a missing A base at position 1,234 in orf3 among 4 class A strains (QYT, ZB, ZHX, and 
LX), which might infer the inactivation of the second domain of Orf3 due to frameshift mutation [9]. 
One of the variable residues among the CstII versions can result in either a mono-functional CstII 
(Thr51) or a bi-functional CstII (Asn51), so it has been suggested that the expression of different 
ganglioside-like structures might have an impact on the outcome of the GBS [19]. The alignment of 
the Cst-II protein sequence verified that only a class A strain (QYT) possessed the residue Asn51. 
Phase variation using homopolymeric G tracts was responsible for some of the variations in LOS outer 
core structures [9,11]. It still needs to be determined whether orf23 and orf25 in the class H and P loci 
might exhibit different enzymatic specificities until the LOS structures for all of these strains are 
determined.   
In this study, we found classes H (strain LC) and P (strain LL and ZX) shared similar gene content 
and organization, besides the deletion–insertion event of orf28 and orf39 with Classes E and H. The 
orf28 gene was clearly missing in the Class H strain (LC) where orf26 was disrupted by orf39. Indeed, 
the deletion–insertion event of orf28 between class H and class P resulted in LOS differences, which 
led to a truncated LOS, as observed by SDS-PAGE (Figure 1). Based on BLAST searches, orf28 was 
proposed to encode a putative glycosyltransferase and orf39  was proposed to encode a putative 
butyryltransferase that was involved in the synthesis of the O-antigen of E. coli O91 [17].   
Parker et al demonstrated that most of the GBS-associated strains (12 of 16 GBS strains) were 
HS:19 or HS:41, and 15 of them belonged to Class A, one belonged to Class C[8]. We found that only 
C. jejuni ZB and LXC were HS:19 and belonged to Class A. This reflected that the Penner serotype is 
not determined by the LOS characters. 
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Figure 1. SDS-gels followed by silver staining of LOS extracts from C. jejuni LC (class H) 
and ZX (class P). 
 
3. Materials and Methods 
3.1. Bacteria Identification and Serotyping 
The eight C. jejuni strains were isolated from the stool specimens of eight GBS patients in the 
Second Hospital of Hebei Medical University in 1993. The isolates were cultured on Columbia agar 
supplemented with 5% sheep blood under micro-aerophilic conditions (5% O2, 10% CO2, and 85% N2) 
at 42
oC for 24 h. Bacteria colonies were characterized by Gram stain, oxidase, catalase tests, and API 
Campy identification system test (API, REF 20800). Campylobacter species-specific PCR for C. jejuni, 
C.  coli, C.  lari, C.  upsaliensis,  and  C.  fetus  were performed according to previous reports. The 
identified C. jejuni isolates were serotyped by the heat-stable (HS) serotyping scheme of Penner and 
Hennessy using a commercial 25 Penner heat-stable antisera set (Campylobacter Antisera Seiken Set, 
Denka Seiken Co., Tokyo) previously described. The serotype results are listed in Table 1. 
Table 1. Campylobacter jejuni strains used in this study. 
Strain no.  Isolated Time  Isolated Place  Subtype (GBS)  Penner type (HS)  LOS locus class 
LLCj  1993  HeiBei Province  AMAN  37  P 
ZXCj  1993  HeiBei Province  AMAN  37  P 
LCCj  1993  HeiBei Province  AIDP  ND  H 
LXCCj  1993  HeiBei Province  AMAN  19  A 
QYTCj  1993  HeiBei Province  AMAN  2  A 
ZBCj  1993  HeiBei Province  AMAN  19  A 
ZHXCj  1993  HeiBei Province  AMAN  ND  A 
XWMCj  1993  HeiBei Province  AMAN  ND  F 
Notes: AMAN: acute motor axonal neuropathy; AIDP: acute inflammatory demyelinating polyneuropathy; 
ND: not determined. 
14.4 
18.4 
25.0 
35.0.
 
45.0 
66.2 
35.0.
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3.2. PCR and PCR Products Sequencing 
Genomic DNA of each strain was extracted with the DNeasy tissue kit (QIAGEN, USA). For the 
different size of PCR products, six pairs of primers were used based on the sequences of C. jejuni 
NCTC 11168 and 81116 LOS loci. The primers in LOS loci are listed in Table 2. PCR products were 
purified by PCR gel extraction kit (QIAGEN) and cloned in vector pGEM-T. The inserts were 
sequenced by primer walking with an ABI Prism Big Dye Terminator (v3.1) cycle sequencing ready 
reaction kit (v5.0). 
Table 2. Primers used in this Study. 
Primer no.  Primer sequence5’-3’ 
P1 
a  AAAGAATACGAATTTGCTAAAGAGG 
P2
 b  ATCATAAAAATCACTTGCCAAAACT 
P3
 b  AATTTTCCAAGAGGAGCACATGCAC 
P4
 b  CTATGGTGTAAGTGGGCATTGGGCT 
P5
 b  AAAAGCCCAATGCCCACTTACAC 
P6 
a  TTGCCAAGGTGAAGTTTGAGTAA 
P7 
c  ACATATAGACCCCTGAGGTAATTCTTT 
P8 
c  GTTATTATTGCTGGAAATGGACCAAGT 
a  P1P6 used to amplify the LOS biosynthesis loci of C. jejuni XWM, which were located 
on orf1 and orf13 respectively, as reported previously [9]. 
b  P1P2, P3P4 and P5P6 were used to amplify the LOS biosynthesis loci of C. jejuni LL, 
ZX and LC. P2P3 and P4P5 were located on orf25 and orf30 respectively from strain 
81116. 
c  P1P7 and P8P6 were used to amplify the LOS biosynthesis loci of C. jejuni QYT, LX, 
ZB and ZHX . P7 and P8 were located on orf7 from NCTC11168. 
3.3. DNA Sequence Alignment and Assigned GenBank Accession Number 
The whole DNA sequence of the LOS biosynthesis loci of eight GBS-associated C. jejuni strains 
were compared with 19 published classes loci (Class A-S) that belonged to ATCC43432(A), 
ATCC43449(B), NCTC11168(C), LIO87(D), 81116(E), RM1170(F), ATCC43437(G), ATCC43431(H), 
RM1850(I), RM1508(J),  GB24(K), RM3435(L),  RM1503(M),  RM2095(N), RM3423(O), GB4(P), 
RM3437(Q), GC149(R), and RM3419(S), which  GenBank  accession numbers are AF215689, 
AF401529, AL139077, AF400669, AJ131360, AY434498, AY436358,  AF411225,  EU404107, 
EU404104, AY573817, EU404111, EF140720, AY816330, EF143352, AY943308, EU404112, 
AY962325, and EU404110, respectively. 
The nucleotide sequences of LOS biosynthesis loci from eight GBS-associated C. jejuni strains 
were deposited in GenBank and were assigned with the accession numbers as follows: LLCj LOS 
locus, DQ535890; QYTCj LOS locus, DQ864651; ZXCj LOS locus, DQ535891; ZBCj LOS locus, 
DQ864653;  ZHXCj  LOS locus, DQ864652; LCCj LOS locus, DQ535892; LXCCj LOS locus, 
DQ864650; XWMCj LOS locus, EF176584. 
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4. Conclusions   
In the present study, the LOS structure of four GBS associated C. jejuni strains from China were 
identified as class A. Three classes (classes F, H and P) without the genes required for expression of 
ganglioside mimicry were found in other four GBS associated strains. Co-infections with multiple C. 
jejuni strains occur in GBS patients might be an alternative explanation to these classes. Further LOS 
structure analysis would be helpful to explore the mechanism of C. jejuni associated GBS. 
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